Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Eom Pharmaceutical Holdings Inc (IMUC)

Eom Pharmaceutical Holdings Inc (IMUC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 0
  • Shares Outstanding, K 0
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,310 K
  • 60-Month Beta 0.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade IMUC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 09/30/19
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1421 +47.78%
on 04/11/24
0.2100 unch
on 05/10/24
+0.0789 (+60.18%)
since 04/10/24
3-Month
0.1100 +90.91%
on 04/05/24
0.3000 -30.00%
on 03/11/24
-0.0400 (-16.00%)
since 02/09/24
52-Week
0.1100 +90.91%
on 04/05/24
0.4000 -47.50%
on 07/06/23
-0.1100 (-34.38%)
since 05/10/23

Most Recent Stories

More News
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil

/PRNewswire/ -- EOM Pharmaceutical Holdings, Inc (OTC: IMUC) ("EOM") today announced the results of its completed clinical trial in hospitalized COVID-19...

IMUC : 0.2100 (+40.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

EOM Pharmaceuticals Inc. is a privately held, clinical-stage pharmaceutical company. It focus on advancing novel immunomodulatory and retinal disease drug agents to address a range of inflammatory, viral, retinal and other diseases. EOM Pharmaceuticals Inc., formerly known as ImmunoCellular Therapeutics...

See More

Key Turning Points

3rd Resistance Point 0.2100
2nd Resistance Point 0.2100
1st Resistance Point 0.2100
Last Price 0.2100
1st Support Level 0.2100
2nd Support Level 0.2100
3rd Support Level 0.2100

See More

52-Week High 0.4000
Fibonacci 61.8% 0.2892
Fibonacci 50% 0.2550
Fibonacci 38.2% 0.2208
Last Price 0.2100
52-Week Low 0.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar